Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
David M. Elliott, Narendra P. Singh, Prakash Nagarkatti, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia, Emilio Sanseviero, Dmitry I. Gabrilovich
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 485-498
Open Access | Times Cited: 1239
Immune Responses Regulated by Cannabidiol
James M. Nichols, Barbara L.F. Kaplan
Cannabis and Cannabinoid Research (2019) Vol. 5, Iss. 1, pp. 12-31
Open Access | Times Cited: 235
Medical Use of Cannabinoids
Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez
Drugs (2018) Vol. 78, Iss. 16, pp. 1665-1703
Closed Access | Times Cited: 229
Cannabinoids: Therapeutic Use in Clinical Practice
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3344-3344
Open Access | Times Cited: 145
An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 473-473
Open Access | Times Cited: 22
Beyond THC and Endocannabinoids
Pál Pacher, Natalya M. Kogan, Raphael Mechoulam
The Annual Review of Pharmacology and Toxicology (2019) Vol. 60, Iss. 1, pp. 637-659
Closed Access | Times Cited: 143
Cannabidiol prevents LPS‐induced microglial inflammation by inhibiting ROS/NF‐κB‐dependent signaling and glucose consumption
Maurício dos Santos Pereira, Franscisco S. Guimarães, Elaine Aparecida Del Bel, et al.
Glia (2019) Vol. 68, Iss. 3, pp. 561-573
Closed Access | Times Cited: 131
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
Zinah Zamil Al-Ghezi, Philip Brandon Busbee, Hasan Alghetaa, et al.
Brain Behavior and Immunity (2019) Vol. 82, pp. 25-35
Open Access | Times Cited: 125
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies
Frances Henshaw, Lauren S. Dewsbury, Chai K. Lim, et al.
Cannabis and Cannabinoid Research (2021) Vol. 6, Iss. 3, pp. 177-195
Open Access | Times Cited: 100
Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
Zinah Zamil Al-Ghezi, Kathryn Miranda, Mitzi Nagarkatti, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 76
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5251-5251
Open Access | Times Cited: 28
Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases
Bahareh Abd‐Nikfarjam, Amirhossein Dolati‐Somarin, Vafa Baradaran Rahimi, et al.
BioFactors (2023) Vol. 49, Iss. 3, pp. 560-583
Closed Access | Times Cited: 24
Cannabinoids in the Modulation of Oxidative Signaling
Cristina Pagano, Beatrice Savarese, Laura Coppola, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2513-2513
Open Access | Times Cited: 22
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
AhR Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Immunosuppressive Activity through Regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p That Target Anti-Inflammatory Genes
Wurood Hantoosh Neamah, Narendra P. Singh, Hasan Alghetaa, et al.
The Journal of Immunology (2019) Vol. 203, Iss. 7, pp. 1830-1844
Open Access | Times Cited: 74
The Yin and Yang of Myeloid Derived Suppressor Cells
Snehil Budhwar, Priyanka Verma, Rachna Verma, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 65
The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation—Evidence from In Vivo Studies
Daniela Călina, Ana Maria Bugă, Mihaela Mitroi, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2395-2395
Open Access | Times Cited: 61
Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
Marcin Ożarowski, Tomasz M. Karpiński, Aleksandra Zielińska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4294-4294
Open Access | Times Cited: 53
Dectin-1 limits autoimmune neuroinflammation and promotes myeloid cell-astrocyte crosstalk via Card9-independent expression of Oncostatin M
M. Elizabeth Deerhake, Keiko Danzaki, Makoto Inoue, et al.
Immunity (2021) Vol. 54, Iss. 3, pp. 484-498.e8
Open Access | Times Cited: 52
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
Claudio Giuliano, Francavilla Miriam, Gerardo Ongari, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8920-8920
Open Access | Times Cited: 52
Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
Alessia Furgiuele, Marco Cosentino, Marco Ferrari, et al.
Journal of Neuroimmune Pharmacology (2021) Vol. 16, Iss. 2, pp. 251-269
Open Access | Times Cited: 44
Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders
Muhammad Yousaf, Dennis Chang, Yang Liu, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4961-4961
Open Access | Times Cited: 34
Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination
Victor Longoria, Hannah Parcel, Bameelia Toma, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 539-539
Open Access | Times Cited: 28
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top